Nanoencapsulation modulates aspartame metabolite exposure: Toxicokinetic, mechanistic, and pharmacological evaluation in a glucocorticoid dysfunction model.

Toxicology and applied pharmacology2026Fawzy SF, Newairy AA, Ghareeb DA, et al.

Study designOther primary literature

SubjectAnimal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AnimalsAspartameChitosanDrug CompoundingGlucocorticoidsMaleNanoparticlesOsteoporosisOxidative StressPhenylalanineRatsRats, Sprague-DawleySweetening AgentsToxicokinetics

DOI 10.1016/j.taap.2026.117827

PMID 42002150

View source →